Virtus ETF Advisers LLC Ascendis Pharma A/S Transaction History

Virtus ETF Advisers LLC

$234 Million
Q4 2024

A detailed history of Virtus ETF Advisers LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 2,676 shares of ASND stock, worth $409,374. This represents 0.16% of its overall portfolio holdings.

Number of Shares

2,676

Previous 2,576 3.88%

Holding current value

$409,374

Previous $384,000 4.17%

% of portfolio

0.16%

Previous 0.19%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$122.0 - $146.6 $12,200 - $14,660	100 Added 3.88%	2,676 $368,000
Q2 2024 Aug 14, 2024	SELL	$121.07 - $153.67 $72,157 - $91,587	-596 Reduced 18.79%	2,576 $351,000
Q1 2024 May 15, 2024	BUY	$123.45 - $159.4 $56,293 - $72,686	456 Added 16.79%	3,172 $479,000
Q4 2023 Feb 15, 2024	SELL	$86.1 - $127.36 $56,137 - $83,038	-652 Reduced 19.36%	2,716 $342,000
Q3 2023 Nov 07, 2023	SELL	$86.5 - $103.97 $37,541 - $45,122	-434 Reduced 11.42%	3,368 $315,000
Q2 2023 Aug 14, 2023	BUY	$69.96 - $97.84 $88,569 - $123,865	1,266 Added 49.92%	3,802 $339,000
Q1 2023 May 15, 2023	BUY	$104.9 - $126.78 $4,720 - $5,705	45 Added 1.81%	2,536 $271,000
Q4 2022 Feb 14, 2023	SELL	$99.42 - $131.97 $40,662 - $53,975	-409 Reduced 14.1%	2,491 $304,000
Q3 2022 Nov 14, 2022	BUY	$84.03 - $110.23 $3,697 - $4,850	44 Added 1.54%	2,900 $299,000
Q2 2022 Aug 12, 2022	BUY	$78.08 - $117.61 $10,462 - $15,759	134 Added 4.92%	2,856 $265,000
Q4 2021 Feb 14, 2022	BUY	$127.1 - $169.66 $145,021 - $193,582	1,141 Added 72.17%	2,722 $366,000
Q3 2021 Nov 15, 2021	SELL	$112.67 - $176.92 $9,351 - $14,684	-83 Reduced 4.99%	1,581 $252,000
Q2 2021 Aug 10, 2021	BUY	$121.62 - $145.29 $2,797 - $3,341	23 Added 1.4%	1,664 $219,000
Q1 2021 May 17, 2021	BUY	$124.92 - $173.33 $3,372 - $4,679	27 Added 1.67%	1,641 $211,000
Q4 2020 Feb 12, 2021	SELL	$151.2 - $182.76 $90,871 - $109,838	-601 Reduced 27.13%	1,614 $269,000
Q3 2020 Nov 13, 2020	SELL	$134.29 - $154.32 $39,749 - $45,678	-296 Reduced 11.79%	2,215 $342,000
Q2 2020 Aug 05, 2020	SELL	$110.87 - $156.01 $67,187 - $94,542	-606 Reduced 19.44%	2,511 $371,000
Q1 2020 May 14, 2020	SELL	$97.01 - $145.11 $43,848 - $65,589	-452 Reduced 12.66%	3,117 $351,000
Q4 2019 Feb 13, 2020	BUY	$91.45 - $139.12 $134,522 - $204,645	1,471 Added 70.11%	3,569 $497,000
Q3 2019 Nov 12, 2019	SELL	$95.8 - $118.9 $11,112 - $13,792	-116 Reduced 5.24%	2,098 $202,000
Q2 2019 Aug 13, 2019	SELL	$107.11 - $132.09 $218,075 - $268,935	-2,036 Reduced 47.91%	2,214 $255,000
Q1 2019 May 14, 2019	SELL	$62.15 - $129.99 $33,498 - $70,064	-539 Reduced 11.25%	4,250 $500,000
Q4 2018 Feb 05, 2019	BUY	$55.16 - $69.67 $264,161 - $333,649	4,789 New	4,789 $300,000

Others Institutions Holding ASND

# of Institutions

236

Shares Held

60.2M

Call Options Held

80.3K

Put Options Held

216K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $8.54B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Ascendis Pharma A/S Transaction History